TY - JOUR
T1 - The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation
AU - Kulicke, Corinna A
AU - De Zan, Erica
AU - Hein, Zeynep
AU - Gonzalez-Lopez, Claudia
AU - Ghanwat, Swapnil
AU - Veerapen, Natacha
AU - Besra, Gurdyal S
AU - Klenerman, Paul
AU - Christianson, John C
AU - Springer, Sebastian
AU - Nijman, Sebastian
AU - Cerundolo, Vincenzo
AU - Salio, Mariolina
PY - 2022/2
Y1 - 2022/2
N2 - The monomorphic antigen-presenting molecule major histocompatibility complex-I-related protein 1 (MR1) presents small-molecule metabolites to mucosal-associated invariant T (MAIT) cells. The MR1-MAIT cell axis has been implicated in a variety of infectious and noncommunicable diseases, and recent studies have begun to develop an understanding of the molecular mechanisms underlying this specialized antigen presentation pathway. However, proteins regulating MR1 folding, loading, stability, and surface expression remain to be identified. Here, we performed a gene trap screen to discover novel modulators of MR1 surface expression through insertional mutagenesis of an MR1-overexpressing clone derived from the near-haploid human cell line HAP1 (HAP1.MR1). The most significant positive regulators identified included β2-microglobulin, a known regulator of MR1 surface expression, and ATP13A1, a P5-type ATPase in the endoplasmic reticulum (ER) not previously known to be associated with MR1-mediated antigen presentation. CRISPR/Cas9-mediated knockout of ATP13A1 in both HAP1.MR1 and THP-1 cell lines revealed a profound reduction in MR1 protein levels and a concomitant functional defect specific to MR1-mediated antigen presentation. Collectively, these data are consistent with the ER-resident ATP13A1 being a key posttranscriptional determinant of MR1 surface expression.
AB - The monomorphic antigen-presenting molecule major histocompatibility complex-I-related protein 1 (MR1) presents small-molecule metabolites to mucosal-associated invariant T (MAIT) cells. The MR1-MAIT cell axis has been implicated in a variety of infectious and noncommunicable diseases, and recent studies have begun to develop an understanding of the molecular mechanisms underlying this specialized antigen presentation pathway. However, proteins regulating MR1 folding, loading, stability, and surface expression remain to be identified. Here, we performed a gene trap screen to discover novel modulators of MR1 surface expression through insertional mutagenesis of an MR1-overexpressing clone derived from the near-haploid human cell line HAP1 (HAP1.MR1). The most significant positive regulators identified included β2-microglobulin, a known regulator of MR1 surface expression, and ATP13A1, a P5-type ATPase in the endoplasmic reticulum (ER) not previously known to be associated with MR1-mediated antigen presentation. CRISPR/Cas9-mediated knockout of ATP13A1 in both HAP1.MR1 and THP-1 cell lines revealed a profound reduction in MR1 protein levels and a concomitant functional defect specific to MR1-mediated antigen presentation. Collectively, these data are consistent with the ER-resident ATP13A1 being a key posttranscriptional determinant of MR1 surface expression.
KW - ATP13A1
KW - HAP1
KW - MHC I-related protein 1 (MR1)
KW - MR1-restricted T cell (MR1T)
KW - P5-type ATPase
KW - antigen presentation
KW - gene trap
KW - mucosal-associated invariant T cell (MAIT)
KW - protein trafficking
UR - http://www.scopus.com/inward/record.url?scp=85123580666&partnerID=8YFLogxK
U2 - 10.1016/j.jbc.2021.101542
DO - 10.1016/j.jbc.2021.101542
M3 - Article
C2 - 34968463
SN - 0021-9258
VL - 298
JO - The Journal of biological chemistry
JF - The Journal of biological chemistry
IS - 2
M1 - 101542
ER -
